Robert Watson

Data Sciences International, Inc. offers telemetry instrumentation and software and services in support of research. Its services include data services, surgical services, validation services and technical training. The firm’s products include implantable and external telemetry, software, signal conditioners, glucose monitoring, infusion pumps and inhalation/exposure systems. The company was founded by Brian P. Brockway in 1984 and is headquartered in St. Paul, MN.

YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.

Part of Adecco Group AG, Adecco Australia Pty Ltd. is a leading staffing and recruitment agency based in Melbourne, Australia. The Australian company provides tailored recruitment services to suit the staffing needs of various industries. Adecco Group conducts its business with integrity and aims to be a driver of positive change. With over 32,000 employees in more than 5,200 branches across 60 countries, the company helps people find jobs and careers every day. Adecco Australia also provides payroll information and additional support to its associates.

Virgin Australia Holdings Ltd. engages in the provision of domestic and international airline services. It operates through the following business segments: Virgin Australia Domestic, Virgin Australia International, Velocity, Tigerair Australia, and Corporate. The Virgin Australia Domestic segment deals with the Australian domestic flying. The Virgin Australia International segment includes Trans-Pacific, Abu Dhabi, Trans-Tasman, Pacific Island and South East Asia. The Velocity segment deals with airline's loyalty program. The Tigerair Australia segment focuses on the Australian domestic flying targeting the budget leisure market. The Corporate segment relates to other airline related services. The company was founded by Brett Alan Godfrey on August 1, 2000 and is headquartered in South Brisbane, Australia.

Cytopia Ltd. primarily engages in discovers and develops drugs to treat cancer and other diseases. The company commenced operations in 1997 in Melbourne, Australia, and has developed kinase enzyme biology and integrated a robust structural biology program with medicinal chemistry & drug development. The company conducts its research and drug development through subsidiaries based in Australia and the USA and also develops small molecule compounds with therapeutic profile for the treatment of cancer. The company has concluded two phase I safety and tolerability studies for its lead anticancer vascular disrupting agent, CYT997. It was founded on August 11, 1997 and is located in Melbourne, VI.

Idameneo (No. 789) Ltd. provides diagnostic and wellness products and services. It offers services through its pathology, diagnostic imaging, medical centers, and pharmacy services divisions. The company is headquartered in St Leonards, Australia..